Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer

NCT05043532 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Pancreatic Neoplasms
Adenocarcinoma of the Pancreas

Interventions

PROCEDURE: 2 passes during EUS-guided fine needle biopsy
PROCEDURE: 3 passes during EUS-guided fine needle biopsy

Sponsor

Orlando Health, Inc.